shortagewatch

Home / Digestive tract and metabolism / Dexamethasone

ATC A01AC02 · Corticosteroids for Local Oral Treatment · updated 4 Nov 2026

Dexamethasone shortage

As of 4 Nov 2026, Dexamethasone has a reported shortage in 1 of the 16 countries we track (United States), covering 17 products from 5 companies.

Is there a Dexamethasone shortage?

Yes. As of 4 Nov 2026, Dexamethasone is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

Countries1/16
Products17packs or presentations
Companies54 listed
Short since8 Feb 20197.7 years ago
Earliest returnnot givencompany estimate
Main reasonNot stated
Free. One email on days with changes. Unsubscribe in one click. Privacy.
United States17 products shortCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

United States
20222023202420252026Dexamethasone Sodium Phosphate Preservative Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)Dexamethasone Sodium Phosphate Preservative Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)Dexamethasone Sodium Phosphate, Injection, 1Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)Dexamethasone Sodium Phosphate, Injection, 1Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)Dexamethasone Sodium Phosphate, Injection, 1Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)Dexamethasone Sodium Phosphate, Injection, 1Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)Dexamethasone Sodium Phosphate, Injection, 1Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)Dexamethasone Sodium Phosphate, Injection, 1Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12)Dexamethasone Sodium Phosphate, Injection, 4Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Fresenius Kabi7 FREViatris4 VTRSHikma3 HIKSomerset2Aurobindo1 AUROPHARMA

Listed: Fresenius Kabi FRE · Xetra, Hikma HIK · LSE, Aurobindo AUROPHARMA · NSE, Viatris VTRS · Nasdaq

Compared with similar medicines

ATC group A01AC · Corticosteroids for Local Oral Treatment
Hydrocortisone2/16Dexamethasone1/16Prednisolone, Combinations1/16

Affected products

CountryProductCompanySinceExpected backReason
USDexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)Fresenius Kabi USA, LLC8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)Somerset Therapeutics, LLC8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)Hikma Pharmaceuticals USA, Inc.8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)Eugia US LLC8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)Fresenius Kabi USA, LLC8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)Mylan Institutional, a Viatris Company8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)Somerset Therapeutics, LLC8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)Fresenius Kabi USA, LLC8 Feb 2019not givenIncreased demand
Demand increase for the drug
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)Hikma Pharmaceuticals USA, Inc.8 Feb 2019not givenIncreased demand
Demand increase for the drug
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)Hikma Pharmaceuticals USA, Inc.8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)Fresenius Kabi USA, LLC8 Feb 2019not givenIncreased demand
Demand increase for the drug
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)Fresenius Kabi USA, LLC8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)Fresenius Kabi USA, LLC8 Feb 2019not givenIncreased demand
Demand increase for the drug
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)Mylan Institutional, a Viatris Company8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)Mylan Institutional, a Viatris Company8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12)Mylan Institutional, a Viatris Company8 Feb 2019not givenNot stated
USDexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)Fresenius Kabi USA, LLC8 Feb 2019not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Dexamethasone shortage?

Yes. As of 4 Nov 2026, Dexamethasone is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

When will Dexamethasone be back in stock?

No return date has been given; United States: no date given. These are company estimates reported to each authority.

Why is Dexamethasone in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Dexamethasone shortages?

Fresenius Kabi, Viatris, Hikma, Somerset, Aurobindo.